Tag: Zydus Lifesciences

WHO prequalifies Zydus’s Typhoid vaccine for UN procurement, stocks rise

Posted on October 23, 2024 by filesadmin

Indian pharmaceutical company Zydus Lifesciences Limited announced today that its typhoid vaccine, ZyVac TCV, has received World Health Organization (WHO)

Zydus Lifesciences to acquire Sterling Biotech’s API Filesadmin.co for Rs 84 crore

Posted on September 17, 2024 by filesadmin

The company is looking for a fermentation-based API business with a manufacturing facility given the high-entry barriers and attractive margin

Zydus Lifesciences gets USFDA nod to mkt Scopolamine transdermal system

Posted on August 30, 2024 by filesadmin

Scopolamine Transdermal System 1 mg/3 days had annual sales of USD 69.6 million in the US, the company said citing

Zydus Lifesciences to acquire 50% stake in Sterling Biotech

Posted on August 24, 2024 by filesadmin

This acquisition will lead to Sterling Biotech becoming a 50:50 joint venture (JV) between Zydus and Perfect Day. | Photo:

Zydus announces licensing deal with Takeda for new GERD drug Vault

Posted on July 17, 2024 by filesadmin

2 min read Last Updated : Jul 17 2024 | 6:59 PM IST Global life sciences company Zydus Lifesciences

Zydus Wellness Q4: Net profit up 3.44% to Rs 150 cr, revenue at 782 cr

Posted on May 14, 2024 by filesadmin

2 min read Last Updated : May 14 2024 | 2:28 PM IST Zydus Wellness Ltd on Tuesday reported

Zydus Lifesciences launches generic drug for overactive bladder in US mkt

Posted on April 22, 2024 by filesadmin

The company is also preparing to launch the 50 mg tablets in the market, it added | Photo: X@ZydusUniverse 2

Stock that will see action today: 26 March 2024

Posted on March 26, 2024 by filesadmin

Sanghvi Mover has incorporated wholly owned subsidiary “Sangreen Renewables Private Limited” to carry out business related to provide full-fledged turnkey